Literature DB >> 12496391

Detection of low-avidity CD4+ T cells using recombinant artificial APC: following the antiovalbumin immune response.

Valérie I Mallet-Designe1, Thomas Stratmann, Dirk Homann, Francis Carbone, Michael B A Oldstone, Luc Teyton.   

Abstract

Subtle differences oppose CD4+ to CD8+ T cell physiologies that lead to different arrays of effector functions. Interestingly, this dichotomy has also unexpected practical consequences such as the inefficacy of many MHC class II tetramers in detecting specific CD4+ T cells. As a mean to study the CD4+ anti-OVA response in H-2(d) and H-2(b) genetic backgrounds, we developed I-A(d)- and I-A(b)-OVA recombinant MHC monomers and tetramers. We were able to show that in this particular system, despite normal biological activity, MHC class II tetramers failed to stain specific T cells. This failure was shown to be associated with a lack of cooperation between binding sites within the tetramer as measured by surface plasmon resonance. This limited cooperativeness translated into a low "functional avidity" and very transient binding of the tetramers to T cells. To overcome this biophysical barrier, recombinant artificial APC that display MHC molecules in a lipid bilayer were developed. The plasticity and size of the MHC-bearing fluorescent liposomes allowed binding to Ag-specific T cells and the detection of low numbers of anti-OVA T cells following immunization. The same liposomes were able, at 37 degrees C, to induce the full reorganization of the T cell signaling molecules and the formation of an immunological synapse. Artificial APC will allow T cell detection and the dissection of the molecular events of T cell activation and will help us understand the fundamental differences between CD4+ and CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496391     DOI: 10.4049/jimmunol.170.1.123

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Mapping and restriction of a dominant viral CD4+ T cell core epitope by both MHC class I and MHC class II.

Authors:  Dirk Homann; Hanna Lewicki; David Brooks; Jens Eberlein; Valerie Mallet-Designé; Luc Teyton; Michael B A Oldstone
Journal:  Virology       Date:  2007-02-21       Impact factor: 3.616

Review 2.  Class II major histocompatibility complex tetramer staining: progress, problems, and prospects.

Authors:  Sabrina S Vollers; Lawrence J Stern
Journal:  Immunology       Date:  2008-03       Impact factor: 7.397

3.  Detection, phenotyping, and quantification of antigen-specific T cells using a peptide-MHC dodecamer.

Authors:  Jun Huang; Xun Zeng; Natalia Sigal; Peder J Lund; Laura F Su; Huang Huang; Yueh-hsiu Chien; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-15       Impact factor: 11.205

4.  Position β57 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset.

Authors:  Louis Gioia; Marie Holt; Anne Costanzo; Siddhartha Sharma; Brian Abe; Lisa Kain; Maki Nakayama; Xiaoxiao Wan; Andrew Su; Clayton Mathews; Yi-Guang Chen; Emil Unanue; Luc Teyton
Journal:  Sci Immunol       Date:  2019-08-30

Review 5.  Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis.

Authors:  Mark M Davis; John D Altman; Evan W Newell
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

6.  Magnetic-activated cell sorting of TCR-engineered T cells, using tCD34 as a gene marker, but not peptide-MHC multimers, results in significant numbers of functional CD4+ and CD8+ T cells.

Authors:  Coen Govers; Cor Berrevoets; Elike Treffers-Westerlaken; Marieke Broertjes; Reno Debets
Journal:  Hum Gene Ther Methods       Date:  2012-06       Impact factor: 2.396

7.  New design of MHC class II tetramers to accommodate fundamental principles of antigen presentation.

Authors:  Elise Landais; Pablo A Romagnoli; Adam L Corper; John Shires; John D Altman; Ian A Wilson; K Christopher Garcia; Luc Teyton
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  T cells control the generation of nanomolar-affinity anti-glycan antibodies.

Authors:  Zinaida Polonskaya; Shenglou Deng; Anita Sarkar; Lisa Kain; Marta Comellas-Aragones; Craig S McKay; Katarzyna Kaczanowska; Marie Holt; Ryan McBride; Valle Palomo; Kevin M Self; Seth Taylor; Adriana Irimia; Sanjay R Mehta; Jennifer M Dan; Matthew Brigger; Shane Crotty; Stephen P Schoenberger; James C Paulson; Ian A Wilson; Paul B Savage; M G Finn; Luc Teyton
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

9.  Tracking epitope-specific T cells.

Authors:  James J Moon; H Hamlet Chu; Jason Hataye; Antonio J Pagán; Marion Pepper; James B McLachlan; Traci Zell; Marc K Jenkins
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

10.  Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells.

Authors:  Lindsay J Edwards; Brian D Evavold
Journal:  J Autoimmun       Date:  2013-07-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.